Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: Role of fasting blood glucose and influence on post-prandial excursions

European Journal of Clinical Investigation

Volumn 32, Issue 3, 2002, Pages 179-186

  Trovati, Mariella ^a   Ponziani, M C ^a   Massucco, P ^a   Anfossi, G ^a   Mularoni, E M ^a   Burzacca, S ^a   Tassone, F ^a   Perna, P ^a   Traversa, M ^a   Cavalot, F ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Hyperglycaemia; Hypoglycaemia; Postprandial blood glucose; Preprandial blood glucose; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAL; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SELF EXAMINATION;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MIDDLE AGED; NURSING STAFF, HOSPITAL; POSTPRANDIAL PERIOD; REPRODUCIBILITY OF RESULTS;

EID: 0036997145     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00965.x     Document Type: Article

References (25)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
2. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
3. Holman RR and Turner RC. Diabetes: the quest for basal normoglycaemia. Lancet 1977;1:1469-74.
4. Holman RR and Turner RC. The basal plasma glucose: a simple, relevant index of maturity onset diabetes. Clin Endocrinol 1980;14:279-86.
5. Hove-Davies S, Simpson RW, Turner RC. Control of maturity-onset diabetes by monitoring fasting blood glucose and body weight. Diabetes Care 1980;3:607-10.
6. Holman RR, Turner RC. Optimizing blood glucose control in Type 2 diabetes: an approach based on fasting blood glucose measurements. Diab Med 1988;5:582-8.
7. Trovati M, Burzacca S, Mularoni E, Massucco P, Cavalot F, Mattiello L et al. Occurrence of low blood glucose concentrations during the afternoon in Type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. Diabetologia 1991;34:662-7.
8. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetic patients. Diabetes Care 1997;20:1822-26.
9. Hanenfeld M, Fisher S, Julius U, Schulze J, Schwanebeck U, Schmechel H, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996;39:1577-83.
10. Ceriello A. The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 2000;16:1-8.
11. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
12. American Diabetes Association. Position Statement: Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care 1998;21 (Suppl. 1):S23-S31.
13. Faiman C, Moorhouse JA. Diurnal variation in the levels of glucose and related substances in healthy and diabetic subjects during starvation. Clin Sci 1967;32:111-26.
14. Bolli GB, Gerich JE. The 'dawn phenomenon' - a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med 1984;310:746-50.
15. Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Calcinaro F et al. Demonstration of a dawn phenomenon in normal human volunteers. Diabetes 1984;33:1150-3.
16. Shapiro ET, Polonsky KS, Copinschi G, Bosson D, Tillil H, Blackman JD et al. Nocturnal elevation of glucose levels during fasting in non-insulin-dependent diabetes. J Clin Endocrinol Metab 1991;72:444-54.
17. Perriello G, Pimenta W, Pampanelli S, Porcellati F, Lepore M, Lucidi P et al. Demonstration of day-night variations in systemic glucose production, but not systemic and muscle glucose uptake in Type 2 diabetes mellitus. Diabetes 1998;47 (Suppl. 1):A41.
18. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I et al. Hierarchy of glycemic thresholds for counterregulatory hormone secreation, symptoms, and cerebral dysfunction. Am J Physiol 1991;260:E67-74.
19. Spyer G, Hattersley A, Amiel S, MacLeod KM. Hypoglycaemic counter-regulation at normal glucose concentrations in patients with well controlled type 2 diabetes. Lancet 2000;356:1970-4.
20. Carroll K, Nestel P. Diurnal variation in glucose tolerance and in insulin secretion in man. Diabetes 1973;22:333-48.
21. Frier BM, Hilsted J. Does hypoglycaemia aggravate the complications of diabetes? Lancet 1985;II:1175-7.
22. Trovati M, Anfossi G, Cavalot F, Massucco P, Mularoni E, Schinco P et al. Studies on mechanisms involved in hypoglycemia-induced platelet activation. Diabetes 1986;35:818-25.
23. Landgraf R. Metaglitinide analogues in the treatment of type 2 diabetes mellitus. Drugs Aging 2000;17:411-25.
24. Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 1999;48:99-105.
25. Rosenfalck AM, Thorsby P, Kiems L, Birkeland K, Dejgaard A, Hanssen KF et al. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients. Acta Diabetol 2000;37:41-6.